IL4 and esophageal squamous cell carcinoma: After adjustment, we identified that IL-4 rs2243263 G>C polymorphism was a risk factor for ESCC development in the BMI ≥ 24 kg/m2 subgroup (GC vs. GG: P=0.030 and GC/CC vs. GG: P=0.018, Table 6).